Home › Therapeutic areas › Dermatology › Recessive Dystrophic Epidermolysis Bullosa
Recessive Dystrophic Epidermolysis Bullosa (2 companies)
Companies with an active program in Recessive Dystrophic Epidermolysis Bullosa.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ELOX | Eloxx Pharmaceuticals | DermatologyRenal Rare | 1 | Phase 2 | $50.2M | 4 |
| INMB | Inmune Bio | Dermatology Rare | 1 | Phase 3 | $35.0M | 1 |
No companies match.